NEW COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS

摘要

There is provided combination products comprising (a) pemirolast, or a pharmaceutically-acceptable salt or solvate thereof; and (b) a compound that inhibits the formation and/or action of angiotensin II, or a pharmaceutically- acceptable salt or solvate thereof. Such combination products find particular utility in atherosclerosis and related conditions.